<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001363'>Craniosynostosis</z:hpo> is the premature fusion of one or more sutures of the skull, which can be syndromic or isolated </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations in FGFR1, FGFR2, or FGFR3, among others, are often responsible for these syndromic cases </plain></SENT>
<SENT sid="2" pm="."><plain>The associated of FGFR3 mutations with <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> has been restricted to three mutations, the common p.Pro250Arg in Muenke syndrome, p.Ala391Glu in <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon syndrome</z:e> with <z:hpo ids='HP_0000956'>acanthosis nigricans</z:hpo>, and p.Pro250Leu identified in a family with isolated <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Other FGFR3 mutations result in various <z:hpo ids='HP_0002652'>skeletal dysplasias</z:hpo>: <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e>, hypochondroplasia, and thanatophoric <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Here, we report a novel mutation in exon 8 (IIIc) of FGFR3, p.Ala334Thr, in a young boy with mild <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The mutation segregated with mild <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> in the family and was absent in 188 <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="6" pm="."><plain>Alanine 334 is evolutionarily conserved in vertebrates and is located at the amino terminus of the Î²F loop in the FGFR3c isoform </plain></SENT>
<SENT sid="7" pm="."><plain>The mutation is predicted to alter the protein tertiary structure which may impair its binding to its ligand, FGF1 </plain></SENT>
<SENT sid="8" pm="."><plain>The identification of a mutation in these clinically <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> disorders can aid recurrence risk assessments </plain></SENT>
<SENT sid="9" pm="."><plain>Although the implementation of a stepwise screening strategy is useful in diagnostics, mutations in unscreened regions of genes associated with <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> may explain a small proportion of <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> cases </plain></SENT>
</text></document>